GSK’s Arexvy Secures Expanded FDA Approval for Younger Adults with High-Risk Conditions, Marking a Pivotal Win in a Challenging Regulatory Landscape
The U.S. Food and Drug Administration (FDA) has granted an expanded approval for GSK’s respiratory...
